TV Video: Hannah - Health Insurance Story. View her fight for insurance coverage for the SCOT Trial, with David Becker, ISN Assistant News Guide.
Tackle Scleroderma! Join/Shop/Donate
SCLERO.ORG by the nonprofit International Scleroderma Network (ISN) is a full-service nonprofit charitable foundation providing stellar research, support, education and awareness
Search sclero.org:

Scleroderma Newsroom
janeywillisHello, I am Janey Willis, ISN News Director and ISN Asst. Webmaster. David Becker, ISN Assistant News Guide researches our Autoimmune News section. Jeannie McClelland, ISN Assistant News Guide, researches Scleroderma Medical and Media News. Assistant News Guide Lisa Bulman posts these stories to our Sclero Forums.
Scleroderma Medical News
Autoimmune News
Media Stories
ISN Website News
Donations & In Memory
New Personal Stories
Scleroderma News Release
Patients to benefit from new website on Pulmonary Arterial Hypertension (PAH)
ALLSCHWIL, SWITZERLAND— TUESDAY 17 JULY 2007— Information on PAH, written specifically for patients, has today been launched on www.PAH-info.com/patients as part of an international awareness campaign supported by Actelion Pharmaceuticals.

The campaign aims to raise awareness of the signs and symptoms of PAH and to improve the number of patients appropriately diagnosed and treated. At the heart of the campaign is www.PAH-info.com, a website dedicated to providing patients and healthcare professionals with accurate and continuously updated information on PAH.

Pulmonary Arterial Hypertension is a life-limiting disease of the pulmonary arteries which connect the lungs to the heart, and it affects an estimated 100,000— 200,000 people around the world. Diagnosis and treatment is often delayed as the early symptoms of PAH— such as breathlessness, chest tightness and fatigue— can be mild and are common to many other conditions such as asthma or anemia.

“Pulmonary Arterial Hypertension affects people of all nations, races, and cultures. Easy-to-use and accurate resources are crucial in educating patients and their families about PAH, medical developments and other relevant news. The Pulmonary Hypertension Association (PHA) therefore welcomes the launch of www.PAH-info.com/patients and congratulates Actelion on their new site,” said Mr Rino Aldrighetti, President of PHA (US), the U.S based association which works closely with domestic and international PAH communities to provide support, education, advocacy and awareness of the disease.

Mr Bruno Kopp, the current vice president of PHA Europe, also believes the new website will be a valuable resource for patients and healthcare professionals. “Pulmonary Arterial Hypertension is a serious and rare disease but current treatment options have significantly improved the outlook for patients. As an educational resource, we expect this website will play an important role in helping to increase the number of correctly diagnosed patients and encourage best practice in the management and treatment of PAH. One of the main aims of PHA Europe is to continue to set up and develop international PAH support associations and this new website is a very exciting and useful tool in bringing about more awareness and information.”

Topics covered in the patient sections of www.PAH-info.com :

  • Pulmonary Arterial Hypertension: what is it?
  • Is Pulmonary Arterial Hypertension very common?
  • What causes Pulmonary Arterial Hypertension?
  • What are common symptoms of Pulmonary Arterial Hypertension?
  • How is Pulmonary Arterial Hypertension classified?
  • How do physicians diagnose Pulmonary Arterial Hypertension?
  • What can be done to treat Pulmonary Arterial Hypertension?  

The website’s patient section is supported by high-quality resources such as an extensive list of worldwide patient associations and professional health organizations and additional sources of information. Patients and other users are also able to register for email updates that inform them when new information has been added to the website. Actelion Pharmaceuticals. Posted 07-17-07. (Also see: Pulmonary Hypertension )

 
Go to ISN SCTC Research Fund Press Release
 
SCLERO.ORG is brought to you by the nonprofit International Scleroderma Network (ISN). The ISN is a full-service nonprofit scleroderma charitable foundation providing stellar research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension.
  1. Post a message in Sclero Forums!
  2. Email: isn@sclero.org
  3. English Email Form
  4. Español Email Form
  5. Italiano Email Form
International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702
United States
Toll Free Hotline in U.S.
Hours: 9am-3pm CST only.
Please leave a complete message, in English.
1-800-564-7099
Direct Line
1-952-583-5735
We are also known as the Scleroderma from A to Z web site.
© Copyright 1998-2009 International Scleroderma Network
All Rights Reserved